Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...

A high burden of heart valve diseases is driving its expansion. India’s transcatheter aortic valve replacement (TAVR) market ...

FORMER Olympian Roger Black has undergone open heart surgery on a condition he has lived with for 47 years. The Team GB ...

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

Kennesaw State University mechanical engineering professor Philippe Sucosky has earned a prestigious American Heart ...

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

Heart disease remains the leading cause of death in the United States, claiming approximately 700,000 lives each year.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.